Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Journal of Cancer Research and Clinical Oncology|December 7, 2021
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patientsMette-Triin Purde, Rebekka Niederer, Nikolaus B Wagner, et al.Swiss Medical Weekly|October 26, 2020
Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational studySarah Lucia Thiel, Myriam Carol Weber, Lorenz Risch, et al.Diagnostics (Basel, Switzerland)|August 23, 2020
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)Marc Kovac, Lorenz Risch, Sarah Thiel, et al.Biomed Research International|November 23, 2020
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical PresentationMartin Risch, Myriam Weber, Sarah Thiel, et al.Clinical Chemistry and Laboratory Medicine|September 1, 2020
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studyRita Christiane Baron, Lorenz Risch, Myriam Weber, et al.Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.American Journal of Hypertension|February 27, 2018
Association of 24-Hour Blood Pressure With Urinary Sodium Excretion in Healthy AdultsJan Gerrit van der Stouwe, Cristian Carmeli, Stefanie Aeschbacher, et al.Disease Markers|February 3, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 AntibodiesMyriam C Weber, Martin Risch, Sarah L Thiel, et al.Iscience|October 21, 2022
Genome-wide analyses identify <i>SCN5A</i> as a susceptibility locus for premature atrial contraction frequencySébastien Thériault, Medea Imboden, Mary L Biggs, et al.Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.Pageof 12